| 1 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
+3,74 % |
+20,67 % |
0,08 |
| 2 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
+3,34 % |
+20,51 % |
0,06 |
| 3 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
+3,02 % |
+18,69 % |
0,05 |
| 4 |
LU0108459040 |
Candriam Equities L Biotechnology C - Thesaurierung |
+2,58 % |
+20,66 % |
0,02 |
| 5 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
+2,49 % |
+19,52 % |
0,02 |
|
|
| 24 |
LU1897414568 |
Janus Henderson Horizon Biotechnology Fund IU2 USD |
-3,83 % |
+27,92 % |
-0,21 |
|
|
| 79 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-9,31 % |
+12,16 % |
-0,94 |
| 80 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-30,85 % |
+30,97 % |
-1,07 |
| 81 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-30,96 % |
+30,96 % |
-1,07 |
| 82 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-13,32 % |
+14,06 % |
-1,10 |
| 83 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-13,93 % |
+14,06 % |
-1,14 |